Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. More Details
No risks detected for 4967 from our risk checks.
Flawless balance sheet with acceptable track record.
Share Price & News
How has Kobayashi Pharmaceutical's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 4967 is less volatile than 75% of JP stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: 4967's weekly volatility (3%) has been stable over the past year.
7 Day Return
JP Personal Products
1 Year Return
JP Personal Products
Return vs Industry: 4967 underperformed the JP Personal Products industry which returned 2% over the past year.
Return vs Market: 4967 underperformed the JP Market which returned 22.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Kobayashi Pharmaceutical's share price compared to the market and industry in the last 5 years?
Simply Wall St News
No news available
Is Kobayashi Pharmaceutical undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 4967 (¥9660) is trading above our estimate of fair value (¥3031.67)
Significantly Below Fair Value: 4967 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 4967 is poor value based on its PE Ratio (39.6x) compared to the JP Personal Products industry average (35.8x).
PE vs Market: 4967 is poor value based on its PE Ratio (39.6x) compared to the JP market (16.4x).
Price to Earnings Growth Ratio
PEG Ratio: 4967 is poor value based on its PEG Ratio (11.2x)
Price to Book Ratio
PB vs Industry: 4967 is overvalued based on its PB Ratio (4.1x) compared to the JP Personal Products industry average (3x).
How is Kobayashi Pharmaceutical forecast to perform in the next 1 to 3 years based on estimates from 9 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4967's forecast earnings growth (3.5% per year) is above the savings rate (0%).
Earnings vs Market: 4967's earnings (3.5% per year) are forecast to grow slower than the JP market (12.9% per year).
High Growth Earnings: 4967's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4967's revenue (2.9% per year) is forecast to grow slower than the JP market (5.2% per year).
High Growth Revenue: 4967's revenue (2.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4967's Return on Equity is forecast to be low in 3 years time (9.9%).
How has Kobayashi Pharmaceutical performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 4967 has high quality earnings.
Growing Profit Margin: 4967's current net profit margins (12.8%) are higher than last year (11.5%).
Past Earnings Growth Analysis
Earnings Trend: 4967's earnings have grown by 6% per year over the past 5 years.
Accelerating Growth: 4967's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4967 had negative earnings growth (-0.6%) over the past year, making it difficult to compare to the Personal Products industry average (-17.7%).
Return on Equity
High ROE: 4967's Return on Equity (10.3%) is considered low.
How is Kobayashi Pharmaceutical's financial position?
Financial Position Analysis
Short Term Liabilities: 4967's short term assets (¥161.1B) exceed its short term liabilities (¥42.0B).
Long Term Liabilities: 4967's short term assets (¥161.1B) exceed its long term liabilities (¥6.0B).
Debt to Equity History and Analysis
Debt Level: 4967 is debt free.
Reducing Debt: 4967 has no debt compared to 5 years ago when its debt to equity ratio was 0.1%.
Debt Coverage: 4967 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4967 has no debt, therefore coverage of interest payments is not a concern.
What is Kobayashi Pharmaceutical current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: 4967's dividend (0.82%) isn’t notable compared to the bottom 25% of dividend payers in the JP market (1.31%).
High Dividend: 4967's dividend (0.82%) is low compared to the top 25% of dividend payers in the JP market (2.99%).
Stability and Growth of Payments
Stable Dividend: 4967's dividends per share have been stable in the past 10 years.
Growing Dividend: 4967's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (31.5%), 4967's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Kazumasa Kobayashi (81 yo)
Mr. Kazumasa Kobayashi has been the Chairman of the Board and Chief Executive Officer of Kobayashi Pharmaceutical Co. LTD. since June 2004. Mr. Kobayashi served as the President of KOBAYASHI Pharmaceutical...
CEO Compensation Analysis
Compensation vs Market: Kazumasa's total compensation ($USD2.67M) is above average for companies of similar size in the JP market ($USD1.41M).
Compensation vs Earnings: Kazumasa's compensation has been consistent with company performance over the past year.
Experienced Board: 4967's board of directors are considered experienced (9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Kobayashi Pharmaceutical Co., Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: Kobayashi Pharmaceutical Co., Ltd.
- Ticker: 4967
- Exchange: TSE
- Founded: 1886
- Industry: Personal Products
- Sector: Household
- Market Cap: JP¥755.055b
- Shares outstanding: 78.16m
- Website: https://www.kobayashi.co.jp
Number of Employees
- Kobayashi Pharmaceutical Co., Ltd.
- KDX Kobayashi Doshomachi Building
- 4-4-10, Doshomachi
Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company provides products in the areas of healthcare, skincare...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/06/18 08:14|
|End of Day Share Price||2021/06/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.